[1]
2025. Comparison of Empagliflozin-Linagliptin with Empagliflozin- Metformin Combination Therapy in Assessing Cardiovascular Profile and Anemia in Type 2 Diabetic Patients. Journal of Bahria University Medical and Dental College. 15, 04 (Oct. 2025), 282–287. DOI:https://doi.org/10.51985/JBUMDC2025572.